Enhancement of innate and adaptive anti-tumor immunity by serum obtained from vascular photodynamic therapy-cured BALB/c mouse
Authors:
- 5 April 2021
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 70 (11) , 3217-3233
Abstract
Photodynamic therapy (PDT) is a clinically approved treatment for various types of cancer. Besides killing the tumor cells directly, PDT has also been reported to trigger anti-tumor immunity. In our previous study, BAM-SiPc-based PDT was shown to induce immunogenic cell death on CT26 murine colon tumor cells in vitro. Using the BALB/c mouse animal model and a vascular-PDT (VPDT) approach, it could also eradicate tumor in ∼ 70% of tumor-bearing mice and elicit an anti-tumor immune response. In the present study, the serum obtained from the VPDT-cured mice was studied and found to possess various immunomodulatory properties. In in vitro studies, it stimulated cytokine secretions of IL-6 and C-X-C motif chemokine ligands 1–3 in CT26 cells through the NF-κB and MAPK pathways. The complement protein C5a boosted in the serum was shown to be involved in the process. The serum also induced calreticulin exposure on CT26 cells and activated dendritic cells. It contained CT26-targeting antibodies which, through the Fc region, induced macrophage engulfment of the tumor cells. In in vivo studies, inoculation of the serum-treated CT26 cells to mice demonstrated a retarded tumor growth with leukocytes, particularly T cells, attracted to the tumor site. In addition, the VPDT-cured mice showed different degrees of resistance against challenge of other types of murine tumor cells, for example, the breast tumor 4T1 and EMT6 cells.Keywords
Funding Information
- Research Grants Council of the Hong Kong Special Administrative Region (14171717)
This publication has 44 references indexed in Scilit:
- How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?Frontiers in Oncology, 2012
- Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent MechanismClinical Cancer Research, 2011
- Assessment of the Evolution of Cancer Treatment TherapiesCancers, 2011
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune ResponsePLOS ONE, 2010
- In vitro induction of immune responses to shared tumor-associated antigens in rhabdomyosarcomaJournal of Pediatric Surgery, 2007
- Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulinBritish Journal of Cancer, 2006
- New Amphiphilic Silicon(IV) Phthalocyanines as Efficient Photosensitizers for Photodynamic Therapy: Synthesis, Photophysical Properties, and in vitro Photodynamic ActivitiesChemistry – A European Journal, 2004
- Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumorsPhotochemical & Photobiological Sciences, 2004
- Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsisThe FASEB Journal, 2003